Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of a Single Dose of Tirzepatide on Esophagogastric Junction Mechanics in Adults With Obesity
NCT07893457Phase 4Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity comparing Placebo with Tirzepatide (2 arms). Primary endpoint: Total Esophageal Acid Exposure Time During 96-Hour Wireless pH Monitoring. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07893457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07893457.